China Biotech Services Holdings Limited
8037.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$492.74M
Close$
Share Statistics
| Market cap | $492.74 Million |
|---|---|
| Enterprise Value | $903.64 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.07 |
| Beta | -0.67 |
| Outstanding Shares | 975,731,150 |
Return
| Return on Equity | -15.97% |
|---|---|
| Return on Assets | -4.24% |
| Return on Invested Capital | -13.46% |
Valuation & Multiples
| P/E Ratio | -14.31 |
|---|---|
| PEG | 6.69 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 9.9 |
| Enterprise Value to EBIT | -10.23 |
| Enterprise Value to Net Income | -27 |
| Total Debt to Enterprise | 0.51 |
| Debt to Equity | 2.15 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About China Biotech Services Holdings Limited
166 employees
CEO: Xiaolin Liu Established in 1996 and based in Causeway Bay, Hong Kong, China Biotech Services Holdings Limited functions as an investment holding company. Its core business involves providing medical laboratory testing and health check services throu...